Marc Brodsky, Josette Hartnett, Kaly Houston, Suzanne J Rose
{"title":"A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context.","authors":"Marc Brodsky, Josette Hartnett, Kaly Houston, Suzanne J Rose","doi":"10.1177/27536130241268240","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%-69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements.</p><p><strong>Objective: </strong>To investigate use of Digest-8 dietary supplement by people who purchased the product from pharmacies for their FGID symptoms.</p><p><strong>Methods: </strong>This pharmacy-based observational study included a convenience sample recruited by flyers at 2 pharmacies upon purchase of Digest-8 dietary supplement to assess symptoms, satisfaction, tolerability, and side-effects through 7 weekly voluntary surveys completed by consenting participants.</p><p><strong>Results: </strong>Twenty-two participants completed an initial survey and a collective total of 59 follow-up surveys. Analysis of follow-up surveys compared to baseline provided pilot data on symptom improvement, satisfaction, tolerability, and low side effect profile.</p><p><strong>Conclusion: </strong>Preliminary findings of the study warrant a follow-up prospective randomized clinical trial to address the study limitations.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"13 ","pages":"27536130241268240"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11273712/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global advances in integrative medicine and health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/27536130241268240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Functional gastrointestinal disorders (FGIDs), a frequent cause of gastrointestinal (GI) symptomology, impact 40%-69% of the United States population. People who suffer from FGIDs often self-manage their symptoms using consumer healthcare products such as dietary supplements.
Objective: To investigate use of Digest-8 dietary supplement by people who purchased the product from pharmacies for their FGID symptoms.
Methods: This pharmacy-based observational study included a convenience sample recruited by flyers at 2 pharmacies upon purchase of Digest-8 dietary supplement to assess symptoms, satisfaction, tolerability, and side-effects through 7 weekly voluntary surveys completed by consenting participants.
Results: Twenty-two participants completed an initial survey and a collective total of 59 follow-up surveys. Analysis of follow-up surveys compared to baseline provided pilot data on symptom improvement, satisfaction, tolerability, and low side effect profile.
Conclusion: Preliminary findings of the study warrant a follow-up prospective randomized clinical trial to address the study limitations.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
